What is the difference between 660nm and 850nm red light therapy?

660nm is a visible red wavelength that penetrates 2–3mm into tissue, primarily targeting skin, wound healing, and cells. 850nm is an invisible near-infrared wavelength that penetrates 4–6cm, reaching deep muscle and tissue. 660nm has 943 peer-reviewed studies; 850nm has 294 — significantly fewer than 810nm (533) or 830nm (624), which are the more heavily studied NIR wavelengths.

Which red light therapy wavelength is best for skin?

For skin applications, the most studied wavelengths are 633nm (55 dermatology studies), 660nm (35 studies), and 830nm (43 studies). The 630–633nm band has the largest evidence base for skin, wound healing, and circulation. 830nm reaches deeper into the dermis and subcutaneous layer. The MitoGLOW LED face mask and MitoPRO+ both target this wavelength range.

Which wavelength is best for muscle recovery?

For muscle recovery, 850nm leads with 68 studies in the muscle category, followed by 808nm (41), 660nm (37), and 830nm (36). The MitoPRO X and MitoADAPT include 810nm, 830nm, and 850nm for comprehensive NIR muscle coverage.

Is 808nm the same as 810nm for red light therapy?

Functionally yes. 808nm is the emission wavelength of the GaAlAs diode laser used in decades of clinical PBM research. 810nm is the LED equivalent. Both fall within the same cytochrome c oxidase absorption peak and produce equivalent photobiomodulation effects at matched irradiance. The 808nm research literature applies directly to 810nm LED devices.

What wavelength is best for brain health and neurological applications?

For brain and neurological applications, 810nm leads with 86 studies, followed by 808nm (64 studies) and 670nm (39 studies). Transcranial photobiomodulation research predominantly uses 808–810nm wavelengths. 670nm has a strong retinal evidence base. The MitoADAPT is the only Mito device that includes 670nm alongside 810nm for comprehensive neuro-optical coverage.

Wavelength Science

Red Light Therapy Wavelengths: The Complete Evidence Guide

Q: What wavelengths are used in red light therapy?

Red light therapy uses wavelengths between approximately 590nm and 1100nm. The most clinically studied wavelengths are the 808–810nm near-infrared band (1,205 studies), 630–633nm red band (989 studies), 660nm (943 studies), and 830nm (624 studies) — based on analysis of over 10,000 peer-reviewed studies.

Not all red light therapy devices are the same — and not all wavelengths do the same thing. This guide covers every clinically studied wavelength from 590nm to 940nm, what the research shows for each one, which conditions they are most studied for, and how to choose based on evidence rather than marketing.

Direct answer

What wavelengths are used in red light therapy? Clinically studied red light therapy wavelengths range from approximately 590nm to 1100nm. The most studied wavelengths in photobiomodulation research are the 808–810nm near-infrared band (1,205 studies), the 630–633nm red band (989 studies), 660nm (943 studies), and 830nm (624 studies) — based on analysis of over 10,000 peer-reviewed studies in the Mito Red Light research database. Different wavelengths penetrate tissue to different depths and are optimised for different applications.

All study counts in this article are drawn from the Mito Red Light Evidence Explorer — a database of 10,000+ peer-reviewed photobiomodulation studies categorised by wavelength, condition, study type, and year. This is the largest publicly accessible PBM research database maintained by any red light therapy company.

Foundations

Why wavelength is the most important specification in red light therapy

Direct answer

Does wavelength matter in red light therapy? Yes — wavelength determines which photoreceptors absorb the light, how deep it penetrates tissue, and therefore which biological effects are produced. A device operating at 850nm delivers fundamentally different effects to one at 660nm, even at identical power levels. Wavelength is not a marketing variable — it is the primary determinant of mechanism and clinical outcome.

The primary mechanism of red light therapy — photon absorption by cytochrome c oxidase in the mitochondrial electron transport chain — is wavelength-dependent. Cytochrome c oxidase has specific absorption peaks in the red (approximately 620–680nm) and near-infrared (approximately 760–940nm) ranges. Light outside these ranges is not efficiently absorbed and produces little to no photobiomodulation effect.

Beyond the primary mitochondrial mechanism, different wavelengths interact differently with other tissue chromophores — haemoglobin, melanin, water, and lipids — which determines penetration depth and tissue specificity. A 633nm photon might travel 1–2mm into tissue. An 810nm photon from the same device can reach 3–5cm, penetrating through skin into muscle, joint capsule, or bone.

The industry problem

Most red light therapy marketing defaults to "660nm and 850nm" as shorthand for a complete device. The peer-reviewed literature tells a different story: 808–810nm and 630–633nm are the most studied wavelength bands globally, and 850nm — despite its marketing dominance — has significantly fewer studies than 830nm or 810nm. Understanding the actual evidence base prevents buyers from confusing marketing with science.

Core concept

The optical window: why therapeutic wavelengths cluster between 600–1000nm

Direct answer

What is the optical window in red light therapy? The optical window (also called the therapeutic window) is the wavelength range — approximately 600–1000nm — where light achieves maximum penetration depth in biological tissue. Below 600nm, haemoglobin and melanin absorb too much light. Above 1000nm, water absorption limits penetration. Within this window, photons can travel centimetres into tissue and reach mitochondria at depth.

The optical window is not arbitrary — it emerges from the absorption spectra of the major tissue chromophores. Haemoglobin (both oxygenated and deoxygenated) absorbs strongly below 600nm, which is why visible light in the blue and green range does not penetrate tissue effectively. Water absorbs strongly above approximately 950–1000nm, which is why far-infrared devices (used in saunas) produce heat rather than photochemical effects.

Within the 600–1000nm window, penetration depth increases broadly with wavelength — red light at 630–660nm reaches primarily the skin and superficial layers, while near-infrared at 808–850nm can penetrate several centimetres, reaching muscles, joints, and even neural tissue.

Wavelength profile

590nm

Amber / Orange-red

VisibleAmber glow

Penetration~1mm (superficial)

Primary targetsSkin surface, retina, mood

Used inMitoPRO X, MitoADAPT

590nm amber light: what it does and what the research shows

Studies in Mito database mentioning 590nm

57 studies

590nm sits at the amber-orange boundary of the visible spectrum — distinct from the red wavelengths that dominate photobiomodulation research. It has a smaller evidence base than the red and NIR wavelengths but covers several interesting applications, particularly for retinal health, skin surface applications, and preliminary mood-related research.

At 590nm, penetration is limited to the most superficial skin layers — making it more relevant for epidermal conditions than deep-tissue work. The 18 retinal studies in our database using near-590nm wavelengths reflect its use in ophthalmology research, where amber and yellow wavelengths interact selectively with retinal chromophores.

Mito devices using 590nm

590nm is included in the MitoPRO X (590, 630, 660, 810, 830, 850nm) and MitoADAPT (590, 630, 660, 670, 810, 830, 850, 940nm) to expand surface-layer coverage and complement the deeper-penetrating NIR wavelengths.

Wavelength profile

630–633nm

Red light · #2 most studied band

VisibleBright red

Penetration1–2mm

Primary targetsSkin, cells, circulation, dermatology

Used inMitoPRO+, MitoPRO X, MitoADAPT

630–633nm: the most studied red wavelength band in the literature

Studies in Mito database mentioning 630 or 633nm (combined)

989 studies — #2 most studied wavelength band globally

The 630–633nm band represents the most extensively studied red light wavelength range in photobiomodulation research, with 989 combined studies in our database. 633nm in particular has been the workhorse of early laser and LED photobiomodulation research — the helium-neon (HeNe) laser, which dominated PBM research for decades, emits at precisely 632.8nm, which is why so much early literature concentrates around this wavelength.

This wavelength range sits squarely within the red absorption peak of cytochrome c oxidase and has the broadest clinical evidence base of any visible wavelength in photobiomodulation. Its penetration is primarily superficial — reaching the epidermis, dermis, hair follicles, and superficial capillaries — making it the dominant wavelength for dermatological, cosmetic, and circulation research.

Top conditions studied with 630–633nm (from our database)

Condition	Studies	Notes
Dermatology	633nm: 55	Acne, wound healing, photorejuvenation
Wound healing	633nm: 53	One of the most replicated PBM findings
Oral health	660nm leads, 633nm: 30+	Mucositis, healing, pain
Circulation	633nm: 23	Microcirculation, blood flow enhancement
Cells (in vitro)	633nm: 42	Mitochondrial activation, ATP production
Immunity	633nm: 16	Immune cell activation, anti-inflammatory
Reproductive system	633nm: 21	Fertility research, IVF applications
Brain / neurology	633nm: 27	Transcranial, neuroprotection

Source: Mito Red Light Evidence Explorer — 10,000+ study database. Browse all studies →

The HeNe legacy

Much of the foundational photobiomodulation evidence was generated using helium-neon lasers emitting at 632.8nm. This is why the 630–633nm band has disproportionately high study counts relative to other red wavelengths — it reflects decades of laser research that predates modern LED devices. Modern LED devices using 630nm deliver the same photochemical benefit at a fraction of the cost.

Mito devices using 630nm

630nm is included in the MitoPRO+ (630, 660, 830, 850nm), MitoPRO X (590, 630, 660, 810, 830, 850nm), and MitoADAPT (590, 630, 660, 670, 810, 830, 850, 940nm).

Wavelength profile

660nm

Red light · #3 most studied globally

VisibleDeep red

Penetration2–3mm

Primary targetsSkin, wounds, cells, oral, hair

Used inMitoPRO+, MitoPRO X, MitoADAPT

660nm: the most studied single wavelength in photobiomodulation

Studies in Mito database mentioning 660nm

943 studies — #3 most studied wavelength globally (and #1 single wavelength)

660nm is the most studied individual wavelength in photobiomodulation research, with 943 studies in our database — the largest count for any single nm value. It sits at the deeper end of the red spectrum, penetrating slightly further than 630–633nm while remaining within the primary cytochrome c oxidase absorption band. It is the dominant wavelength in LED-era PBM research, having largely replaced 633nm as the standard red wavelength for modern devices.

660nm dominates the oral health literature (325 studies in our oral category), wound healing (80 studies), stem cell and regeneration research (29 studies), surgery (26 studies), and respiratory research (33 studies). It is also the most studied wavelength for in vitro cellular research, reflecting its use as a standard reference wavelength in laboratory photobiomodulation protocols.

Top conditions studied with 660nm (from our database)

Condition	Studies	Key findings
Oral health	325	Mucositis prevention/treatment — included in clinical guidelines since 2020
Wound healing	80	Accelerated closure, collagen deposition, reduced infection
Cells (in vitro)	45	ATP production, mitochondrial membrane potential, ROS modulation
Dermatology	35	Photorejuvenation, acne, inflammatory skin conditions
Respiratory	33	Airway inflammation, COVID-19 recovery (Pereira et al., 2022)
Brain	35	Neuroprotection, mood, cognitive function
Oncology	29	Adjunct to cancer therapy, mucositis prevention
Stem cells	29	Differentiation, proliferation, regeneration
Hair	9	Follicular stimulation, androgenic alopecia

Source: Mito Red Light Evidence Explorer — 10,000+ study database. Browse all studies →

Mito Red Light devices use 630nm and 660nm in every panel — the two most studied red wavelengths in the literature. See which device matches your application.

Compare panels →

Wavelength profile

670nm

Deep red

VisibleDeep red

Penetration2–4mm

Primary targetsEyes, brain, skin, development

Used inMitoADAPT only

670nm: the eye and brain wavelength

Studies in Mito database mentioning 670nm

295 studies

670nm is a highly specific wavelength with a disproportionately strong evidence base in retinal and neurological research. The eyes category in our database shows 670nm as the #1 wavelength with 64 studies — far ahead of any other wavelength for ocular applications. Pioneering work by Glen Jeffery at University College London has demonstrated that 670nm exposure can improve retinal function in ageing eyes and improve photoreceptor mitochondrial activity.

670nm also appears prominently in brain research (39 studies) alongside 810nm, consistent with its use in transcranial photobiomodulation protocols. It penetrates slightly deeper than 660nm while remaining comfortably within the red absorption peak of cytochrome c oxidase.

Top conditions studied with 670nm

Condition	Studies	Notes
Eyes / retinal health	64	#1 wavelength for retinal PBM — Jeffery lab, UCL; FDA approval for dry AMD 2024
Brain / neurology	39	Transcranial PBM, neuroprotection, Parkinson's models
Wound healing	34	Tissue repair and regeneration
Development	6	Embryonic development, cellular differentiation

Jeffery G et al. "670nm light improves mitochondrial function and protects against age-related retinal degeneration." Neurobiol Aging. 2017. Source: Mito Red Light Evidence Explorer.

Mito devices using 670nm

670nm is exclusive to the MitoADAPT — the only Mito panel that includes this wavelength alongside the full 8-wavelength spectrum (590, 630, 660, 670, 810, 830, 850, 940nm). The MitoADAPT is the most comprehensively targeted device in the lineup for retinal and neurological applications.

Wavelength profile

808–810nm

Near-infrared · #1 most studied band globally

VisibleInvisible (faint IR glow)

Penetration3–5cm

Primary targetsBrain, bone, joints, muscle, oral

Used inMitoPRO X, MitoADAPT

808–810nm: the most studied NIR wavelength band in the world

Studies in Mito database mentioning 808nm or 810nm (combined)

1,205 studies — #1 most studied wavelength band across all 10,000+ studies

The 808–810nm band is the single most studied wavelength range in photobiomodulation research, with 1,205 combined studies in our database. 808nm dominates because of its use in high-power diode laser research — the gallium aluminium arsenide (GaAlAs) diode laser, which became the clinical standard for deep-tissue PBM, emits at 808nm. Mito devices use 810nm, which falls within the same absorption band and has 533 studies of its own.

At this wavelength, NIR light penetrates 3–5cm into tissue — deep enough to reach joint capsules, muscle belly, subchondral bone, and in transcranial applications, neural tissue. The oral health category alone contains 215 studies using 808nm and 200 using 810nm — reflecting the dominant use of diode lasers in dental photobiomodulation.

Top conditions studied with 808–810nm (from our database)

Condition	Studies (808+810nm)	Key context
Oral health	415	Dominant wavelength for dental PBM — healing, pain, mucositis
Brain / neurology	150	#1 wavelength for transcranial PBM; Parkinson's, TBI, depression research
Bone	71	Fracture healing, osteoporosis, dental osseointegration
Joints	62	Arthritis, cartilage regeneration, synovial inflammation
Muscle	68	Performance, recovery, DOMS reduction
Pain	58	Chronic pain, neuropathic pain, post-surgical pain
Nervous system	69	Peripheral neuropathy, spinal cord, nerve regeneration
Hearing	17	Cochlear, tinnitus, auditory nerve research

Source: Mito Red Light Evidence Explorer — 10,000+ study database. Browse all studies →

808nm vs 810nm: are they the same?

Functionally, yes. 808nm is the emission wavelength of the standard GaAlAs diode laser used in decades of clinical PBM research. 810nm is the LED equivalent used in modern home devices including Mito Red Light. Both wavelengths sit within the same NIR absorption peak of cytochrome c oxidase and produce equivalent photobiomodulation effects at matched irradiance. The 808nm literature applies directly to 810nm devices.

Wavelength profile

830nm

Near-infrared · #4 most studied globally

VisibleInvisible

Penetration3–5cm

Primary targetsBone, pain, joints, muscle, nervous system

Used inMitoPRO+, MitoPRO X, MitoADAPT

830nm: the most studied NIR wavelength in the musculoskeletal literature

Studies in Mito database mentioning 830nm

624 studies — #4 most studied wavelength globally

830nm is the dominant wavelength in musculoskeletal photobiomodulation research, leading the bone (74 studies), pain (61 studies), and joints (30 studies) categories in our database. It represents a slightly longer NIR wavelength than 808–810nm, with comparable penetration depth and a similar cytochrome c oxidase absorption profile.

830nm has a strong presence in the 2025 specialist consensus review published in the Journal of the American Academy of Dermatology, which confirmed PBM efficacy for several conditions. It is the dominant wavelength in dermatological NIR applications (43 studies), where its penetration reaches the dermis and subcutaneous layer — useful for photorejuvenation, collagen stimulation, and wound healing at depth.

Top conditions studied with 830nm

Condition	Studies	Notes
Bone	74	#1 wavelength for bone PBM globally
Pain	61	Chronic pain, nociception, post-surgical
Oral health	129	Healing, pain, bone regeneration
Dermatology	43	Photorejuvenation, wound healing, acne
Joints	30	Arthritis, inflammation, cartilage
Nervous system	35	Peripheral neuropathy, nerve regeneration
Muscle	36	Recovery, performance, fatigue
Thyroid	8	#1 wavelength in thyroid PBM research

Source: Mito Red Light Evidence Explorer — 10,000+ study database. Browse all studies →

Wavelength profile

850nm

Near-infrared

VisibleInvisible

Penetration4–6cm

Primary targetsMuscle, deep tissue, sleep

Used inMitoPRO+, MitoPRO X, MitoADAPT

850nm: heavily marketed, but what does the research actually show?

Studies in Mito database mentioning 850nm

294 studies

850nm is one of the most marketed wavelengths in the consumer red light therapy industry — frequently paired with 660nm as a standard two-wavelength combination. However, with 294 studies in our database, it ranks 7th by study count — behind 808–810nm (1,205), 630–633nm (989), 660nm (943), 830nm (624), 904nm (422), and 670nm (295).

This does not mean 850nm is ineffective — it means the marketing has outpaced the direct evidence base relative to other NIR wavelengths. 850nm leads our muscle category with 68 studies, making it the most evidence-backed wavelength for muscle-specific applications. It also has 6 studies in the sleep medicine category — more than any other wavelength in that relatively new research area.

The honest picture on 850nm

850nm is a legitimate and effective photobiomodulation wavelength. The gap between its marketing prominence and its study count reflects the fact that the consumer industry largely adopted it based on interpolation from adjacent wavelengths (808, 830nm) rather than its own direct evidence. It is included in Mito devices because it adds coverage within the NIR window — but 810nm and 830nm carry a substantially stronger independent evidence base.

Wavelength profile

940nm

Deep near-infrared

VisibleInvisible

Penetration5–7cm (deepest in range)

Primary targetsDeep muscle, joints, bone, fat tissue

Used inMitoADAPT only

940nm: the deepest-penetrating wavelength in the Mito lineup

Studies in Mito database mentioning 940nm

173 studies

940nm sits at the upper edge of the optical window, approaching the point where water absorption begins to limit penetration depth. It offers the deepest tissue penetration of any wavelength in the Mito lineup — estimated at 5–7cm — making it potentially useful for large-muscle groups, deep joint structures, and adipose tissue applications.

940nm has 173 studies in our database, appearing in muscle, joint, and metabolic health research. It is positioned in the MitoADAPT as the "depth extension" wavelength — complementing the 810nm and 830nm that dominate the NIR evidence base, while pushing penetration to its practical maximum within the optical window.

Mito devices using 940nm

940nm is exclusive to the MitoADAPT — the only panel in the Mito lineup that includes this wavelength. The MitoADAPT's 8-wavelength system (590, 630, 660, 670, 810, 830, 850, 940nm) is designed to provide maximum spectral coverage from superficial skin layers through to the deepest accessible tissue planes.

The MitoADAPT is the only home device using all 8 wavelengths — 590nm through 940nm. Built for full-spectrum photobiomodulation from skin surface to deep tissue.

View MitoADAPT →

Reference table

Complete wavelength comparison: all Mito wavelengths side by side

All study counts from the Mito Red Light Evidence Explorer database (10,000+ studies).

Wavelength	Type	Studies	Penetration	Top applications	In Mito devices
590nm	Amber	57	~1mm	Retina, skin surface, mood	MitoPRO X, MitoADAPT
630–633nm	Red	989	1–2mm	Skin, wound healing, circulation, cells	All 3 panels
660nm	Red	943	2–3mm	Oral, wound healing, cells, dermatology	All 3 panels
670nm	Deep red	295	2–4mm	Eyes (#1), brain, wound healing	MitoADAPT only
808–810nm	NIR	1,205	3–5cm	Brain (#1), bone, oral, joints, muscle	MitoPRO X, MitoADAPT
830nm	NIR	624	3–5cm	Bone (#1), pain, dermatology, thyroid	All 3 panels
850nm	NIR	294	4–6cm	Muscle (#1 wavelength), sleep, deep tissue	All 3 panels
940nm	Deep NIR	173	5–7cm	Deepest tissue, metabolic, joints	MitoADAPT only

Clinical reference

Which wavelength for which condition? Evidence-based recommendations

The following recommendations are based on which wavelengths have the highest study counts for each condition in the Mito Red Light database of 10,000+ peer-reviewed studies — not on marketing or manufacturer claims.

Condition / Goal	Most studied wavelengths	Studies	Recommended Mito device
Skin rejuvenation / anti-aging	633nm, 830nm, 660nm	472 in dermatology	MitoPRO+ or MitoGLOW
Wound healing	660nm, 633nm, 670nm	596 studies	Any Mito panel
Muscle recovery & performance	850nm, 808nm, 660nm, 830nm	432 studies	MitoPRO X, MitoADAPT
Joint pain & arthritis	808nm, 830nm, 904nm	259 studies	MitoPRO X, MitoADAPT
Bone health	830nm, 808nm, 780nm	380 studies	MitoPRO X, MitoADAPT
Brain & cognitive health	810nm, 808nm, 670nm	511 studies	MitoADAPT (includes 670nm)
Pain management	830nm, 904nm, 808nm	409 studies	MitoPRO X, MitoADAPT
Hair growth	655nm, 660nm, 630nm	102 studies	MitoGLOW, MitoPRO+
Eye & retinal health	670nm, 650nm, 633nm	312 studies	MitoADAPT (670nm)
Oral health / dental	660nm, 808nm, 810nm	1,932 studies	Any panel — targeted use
Thyroid	830nm, 850nm, 904nm	24 studies	MitoPRO+, MitoADAPT
Circulation	633nm, 660nm, 808nm	169 studies	Any Mito panel
Immunity	633nm, 660nm, 830nm	95 studies	Any Mito panel
Nervous system / neuropathy	808nm, 830nm, 660nm	293 studies	MitoPRO X, MitoADAPT
Sleep	850nm, 830nm, 660nm	23 studies	Any Mito panel — evening use

All data from the Mito Red Light Evidence Explorer. Study counts reflect references in our database mentioning each wavelength for each category — not the total global literature. Explore the full database →

Product guide

How Mito Red Light uses wavelengths: which device for which goal

Device	Wavelengths	Total	Best for
MitoPRO+	630nm · 660nm · 830nm · 850nm	4	Skin, wound healing, muscle recovery, general wellness. Strongest red evidence (630+660) + core NIR (830+850)
MitoPRO X	590nm · 630nm · 660nm · 810nm · 830nm · 850nm	6	Full red spectrum + #1 NIR band (810nm). Best for deep-tissue, brain, bone, joints, and comprehensive applications
MitoADAPT	590nm · 630nm · 660nm · 670nm · 810nm · 830nm · 850nm · 940nm	8	Complete spectrum. Adds 670nm (eyes/brain) and 940nm (deepest penetration). Maximum coverage from skin surface to deep tissue
MitoGLOW	Red + NIR (LED mask)	—	Facial skin rejuvenation, collagen, acne. Targeted delivery for dermatological applications

Continue learning

Related resources

Database Evidence Explorer: search 10,000+ studies by wavelength & condition Science guide How does red light therapy work? The full science Evidence hub Research Evidence Hub: studies by condition Safety Who should not use red light therapy

Find the right device for your wavelength needs

Every Mito Red Light panel uses wavelengths selected from the highest-evidence bands in the peer-reviewed literature — not from marketing convention.

Compare all panels Explore the research database →

Flagship Panel Series

Entry Panel Series

Specialized

Commercial

Red Light Therapy Skincare

Portable Red Light Therapy

Learn the Science

Mito-Red-Difference

In the Press

Mito Red Light Community

Frequently Asked Questions

Mito Red Light Quiz - Find Which Device is Right For You.

Articles by Topic

Red Light Therapy Wavelengths: The Complete Evidence Guide

Why wavelength is the most important specification in red light therapy

The optical window: why therapeutic wavelengths cluster between 600–1000nm

590nm amber light: what it does and what the research shows

630–633nm: the most studied red wavelength band in the literature

Top conditions studied with 630–633nm (from our database)

660nm: the most studied single wavelength in photobiomodulation

Top conditions studied with 660nm (from our database)

670nm: the eye and brain wavelength

Top conditions studied with 670nm

808–810nm: the most studied NIR wavelength band in the world

Top conditions studied with 808–810nm (from our database)

830nm: the most studied NIR wavelength in the musculoskeletal literature

Top conditions studied with 830nm

850nm: heavily marketed, but what does the research actually show?

940nm: the deepest-penetrating wavelength in the Mito lineup

Complete wavelength comparison: all Mito wavelengths side by side

Which wavelength for which condition? Evidence-based recommendations

How Mito Red Light uses wavelengths: which device for which goal

Related resources

Find the right device for your wavelength needs